bpc-157 human studies safety review BPC 157 in Australia: Benefits, side effects, risks and legality bpc-157 human clinical trials evidence

KLOW concentration at common reconstitution volumes BAC water 2.0 mL Total concentration 40.0 mg/mL GHK-Cu per unit (0.01 mL) ~250 mcg KPV / BPC-157 / TB-500 per unit ~50 mcg each BAC water 3.0 mL (most common) Total concentration 26.7 mg/mL GHK-Cu per unit (0.01 mL) ~167 mcg KPV / BPC-157 / TB-500 per unit ~33 mcg each BAC water 4.0 mL Total concentration 20.0 mg/mL GHK-Cu per unit (0.01 mL) ~125 mcg KPV / BPC-157 / TB-500 per unit ~25 mcg each Higher BAC water volumes give more measurable draws but require larger injection volumes

"Rural infrastructure helps ensure all Coloradans have access to clean and safe drinking water, housing, and safe facilities

Theoretical concerns include unstudied effects in active malignancy (via angiogenesis) and pregnancy

Patients can receive as many as two injections per week based on their goals

What angle should you inject peptides at